A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Kim Wall, whose body had been cut apart, is believed to have died while on a privately built submarine belonging to a Danish inventor.
Parts of Scotland and northern England will start the day with outbreaks of thundery rain before it slowly clears through the day.
The NSPCC has revealed that it dealt with nearly 19,500 calls and emails from concerned adults in the last year relating to child neglect.